Which are the right cells to be used in a bioartificial liver?

Metabolic Brain Disease

Volumn 20, Issue 4, 2005, Pages 327-335

  Chamuleau, Robert A F M ^a   Deurholt, Tanja ^a   Hoekstra, Ruurdtje ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Bioartificial liver; Embryonic stem cell; Hepatocyte; Human fetal liver cell; Immortalized liver cell line

Indexed keywords

TELOMERASE;

ARTIFICIAL LIVER; BIOCHEMISTRY; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL ISOLATION; CELL TYPE; CLINICAL TRIAL; COCULTURE; CONFERENCE PAPER; CRYOPRESERVATION; EMBRYONIC STEM CELL; ENZYME ACTIVITY; ENZYME RECONSTITUTION; FEASIBILITY STUDY; FETUS CELL; HEMATOPOIETIC STEM CELL; HEMODYNAMICS; HEPATOCYTE TRANSPLANTATION; HUMAN; IMMUNOGENICITY; LIVER CELL; LIVER FAILURE; LIVER REGENERATION; LIVER TUMOR; NEUROLOGY; NONHUMAN; PILOT STUDY; STEM CELL; SURVIVAL; SWINE; TUMOR CELL; XENOTRANSPLANTATION; ZOONOSIS;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; FETUS; HEMATOPOIETIC STEM CELLS; HEPATOCYTES; HUMANS; LIVER; LIVER, ARTIFICIAL; STEM CELL TRANSPLANTATION;

SUIDAE; SUS SCROFA;

EID: 29744467490     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11011-005-7914-4     Document Type: Conference Paper

References (42)

1. Adam, R., Cailliez, V., Majno, P., Karam, V., McMaster, P., Caine, R.Y., O'Grady, J., Pichlmayr, R., Neuhaus, P., Otte, J.-B., Hoeckerstedt, K., and Bismuth, H. (2000). Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet 356:621-627.
2. Alison, M.R., Poulsom, R., Jeffery, R., Dhillon, A.P., Quaglia, A., Jacob, J., Novelli, M., Prentice, G., Williamson, J., and Wright, N.A. (2000) Hepatocytes from non-hepatic adult stem cells. Nature 406:257.
3. Allain, J.E., Dagher, I., Mahieu-Caputo, D., Loux, N., Andreoletti, M., Westerman, K., Briand, P., Franco, D., Leboulch, P., and Weber, A. (2002). Immortalization of a primate bipotent epithelial liver stem cell. Proc. Natl. Acad. Sci. U.S.A. 99:3639-3644.
4. Alvarez-Dolado, M., Pardal, R., Garcia-Verdugo, J.M., Fike, J.R., Lee, H.O., Pfeffer, K., Lois, C., Morrison, S.J., and Alvarez-Buylla, A. (2003). Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425:968-973.
5. Avital, I., Feraresso, C., Aoki, T., Hui, T., Rozga, J., Demetriou, A., and Muraca, M. (2002). Bone marrow-derived liver stem cell and mature hepatocyte engraftment in livers undergoing rejection. Surgery 132:384-390.
6. Baquerizo, A., Mhoyan, A., Shirwan, H., Swensson, J., Busuttil, R.W., Demetriou, A.A., and Cramer, D.V. (1997). Xenoantibody response of patients with severe acute liver failure exposed to porcine antigens following treatment with a bioartificial liver. Transplant. Proc. 29:964-965.
7. Carpenter, M.K., Rosler, E.S., Fisk, G.J., Brandenberger, R., Ares, X., Miura, T., Lucero, M., and Rao, M.S. (2004). Properties of four human embryonic stem cell lines maintained in a feeder-free culture system. Dev. Dyn. 229:243-258.
8. Demetriou, A.A., Brown, R.S., Busuttil, R.W., Fair, J., McGuire, B.M., Rosenthal, P., Am Esch, J.S., Lerut, J., Nyberg, S.L., Salizzoni, M., Fagan, F.A., de Hemptinne, B., Broelseh, C.E., Muraca, M., Salmeron, J.M., Rabkin, J.M., Metselaar, H.J., Partt, D., De La Mata, M., McChesney, L.P., Everson, G.T., Lavin, P.T., Stevens, A.C., Pitkin, Z., and Solomon, B.A. (2004). Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann. Surg. 239(5):660-670.
9. Ellis, A.J., Hughes, R.D., Wendon, J.A., Dunne, J., Langley, P.G., Kelly, J.H., Gislason, G.T., Sussman, N.L., and Williams, R. (1996). Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 24:1446-1451.
10. Enosawa, S,, Miyashita, T., Fujita, Y., Suzuki, S., Amemiya, H., Omasa, T., Hiramatsu, S., Suga, K., and Matsumura, T. (2001). In vivo estimation of bioartificial liver with recombinant HepG2 cells using pigs with ischemic liver failure. Cell Transplant. 10:429-33.
11. Fausto, N., and Campbell, J.S. (2003). The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech. Dev. 120:117-130.
12. Flendrig, L.M., la Soe, J.W., Jorning, G.G., Steenbeek, A., Karlsen, O.T., Bovee, W.M., Ladiges, N.C., te Velde, A.A., and Chamuleau, R.A. (1997). In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates. J. Hepatol. 26:1379-1392.
13. Fujii, M., Yamashita, Y., Shirabe, K., Ijima, H., Nakazawa, K., Funatsu, K., and Sugimachi, K. (2001). [Basic study about the development of the hybrid-artificial liver support system using human hepatoma cell lines (Hep G2, Huh 7): effects on liver functions by extracellular matrix (type I collagen) in monolayer culture]. Fukuoka Igaku Zasshi 92:299-305.
14. Hoekstra, R., and Chamuleau, R.A. (2002). Recent developments on human cell lines for the bioartificial liver. Int. J. Artif. Organs 25:182-191.
15. Kobayashi, N., Fujiwara, T., Westerman, K.A., Inoue, Y., Sakaguchi, M., Noguchi, H., Miyazaki, M., Cai, J., Tanaka, N., Fox, I.J., and Leboulch, P. (2000). Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science 287:1258-1262.
16. Lagasse, E., Connors, H., Al Dhalimy, M., Reitsma, M., Dohse, M., Osborne, L., Wang, X., Finegold, M., Weissman, I.L., and Grompe, M. (2000). Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. 6:1229-1234.
17. Millis, J.M., Cronin, D.C., Johnson, R., Conjeevaram, H., Faust, T.W., Trevino, S., Conlin, C., Brotherton, J., Traglia. D., Maguire, P., and Dane, G. (2001). Bioartificial liver support: Report of the longest continuous treatment with human hepatocytes. Transplant. Proc. 33:1935.
18. Moorman, A.F., Vermeulen, J.L., Charles, R., and Lamers, W.H. (1989). Localization of ammonia-metabolizing enzymes in human liver: Ontogenesis of heterogeneity. Hepatology 9:367-372.
19. Newsome, P.N., Johannessen, I., Boyle, S., Dalakas, E., McAulay, K.A., Samuel, K., Rae, F., Forrester, L., Turner, M.L., Hayes, P.C., Harrison, D.J., Bickmore, W.A., and Plevris, J.N. (2003). Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cellular fusion. Gastroenterology 124:1891-1900.
20. Nyberg, S.L., Remmel, R.P., Mann, H.J., Peshwa, M.V., Hu, W.S., and Cerra, F.B. (1994). Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver. Ann. Surg. 220:59-67.
21. Okitsu, T., Kobayashi, N., Jun, H.S., Shin, S., Kim, S.J., Han, J., Kwon, H., Sakaguchi, M., Totsugawa, T., Kohara, M., Westerman, K.A., Tanaka, N., Leboulch, P., and Yoon, J.W. (2004). Transplantation of reversibly immortalized insulin-secreting human hepatocytes controls diabetes in pancreatectomized pigs. Diabetes 53:105-112.
22. Paradis, K., Langford, G., Long, Z., Heneine, W., Sandstrom, P., Switzer, W.M., Chapman, L.E., Lockey, C., Onions, D., and Otto, E. (1999). Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science 285:1236-1241.
23. Parent, R., Marion, M.J., Furio, L., Trepo, C., and Petit, M.A. (2004). Origin and characterization of a human bipotent liver progenitor cell line. Gastroenterology 126:1147-1156.
24. Petersen, B.E., Bowen, W.C., Patrene, K.D., Mars, W.M., Sullivan, A.K., Murase, N., Boggs, S.S., Greenberger, J.S., and Goff, J.P. (1999). Bone marrow as a potential source of hepatic oval cells. Science 284:1168-1170.
25. Sato, N., Meijer, L., Skaltsounis, L., Greengard, P., and Brivanlou, A.H. (2004). Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 10:55-63.
26. Sauer, I.M., Zeilinger, K., Obermayer, N., Pless, G., Grunwald, A., Pascher, A., Mieder, T., Roth, S., Goetz, M., Kardassis, D., Mas, A., Neuhaus, P., and Gerlach, J.C. (2002). Primary human liver cells as source for modular extracorporeal liver support - a preliminary report. Int. J. Artif. Organs 25:1001-1005.
27. Schuldiner, M., Yanuka, O., Itskovitz-Eldor, J., Melton, D.A., and Benvenisty, N. (2000). Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A 97:11307-11312.
28. Schwartz, R.E., Reyes, M., Koodie, L., Jiang, Y., Blackstad, M., Lund, T., Lenvik, T., Johnson, S., Hu, W.S., and Verfaillie, C.M. (2002). Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J. Clin. Invest. 109:1291-1302.
29. Shirahashi, H., Wu, J., Yamamoto, N., Catana, A., Wege, H., Wager, B., Okita, K., and Zern, M.A. (2004). Differentiation of human and mouse embryonic stem cells along a hepatocyte lineage. Cell Transplant. 13:197-211.
30. Smith, D.D., Jr., and Campbell, J.W. (1988). Distribution of glutamine synthetase and carbamoyl-phosphate synthetase I in vertebrate liver. Proc. Natl. Acad. Sci. U.S.A. 85:160-164.
31. Suzuki, A., Nakauchi, H., and Taniguchi, H. (2003). In vitro production of functionally mature hepatocytes from prospectively isolated hepatic stem cells. Cell Transplant. 12:469-473.
32. Takahashi, M., Ishikura, H., Takahashi, C., Nakajima, Y., Matsushita, M., Matsue, H., Sato, K., Noto, H., Taguchi, K., Koike, M., Nishuikawa, M., Kamachi, H., Kon, H., Uchino, J., and Yoshiki, T. (1993). Immunologic considerations in the use of cultured porcine hepatocytes as a hybrid artificial liver. Anti porcine hepatocyte human serum. ASAIO J. 39:M242-M246.
33. te Velde, A.A., Flendrig, L.M., Ladiges, N.C., and Chamuleau, R.A. (1997). Possible immunological problems of bioartificial liver support. Int. J. Artif. Organs 20:418-421.
34. Theise, N.D., Nimmakayalu, M., Gardner. R., Illei, P.B., Morgan, G., Teperman, L., Henegariu, O., and Krause, D.S. (2000). Liver from bone marrow in humans. Hepatology 32:11-16.
35. Tsiaoussis, J., Newsome, P.N., Nelson, L.J., Hayes, P.C., and Plevris, J.N. (2001). Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems. Liver Transpl. 7:2-10.
36. van de Kerkhove, M.P., Hoekstra, R., Chamuleau, R.A., and van Gulik, T.M. (2004). Clinical application of bioartificial liver support systems. Ann. Surg. 240:216-230.
37. Wang, X., Willenbring, H., Akkari, Y., Torimaru, Y., Foster, M., Al Dhalimy, M., Lagasse, E., Finegold, M., Olson, S., and Grompe, M. (2003). Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 422:897-901.
38. Wege, H., Le, H.T., Chui, M.S., Liu, L., Wu, J., Giri, R., Malhi, H., Sappal, B.S., Kumaran. V., Gupta, S., and Zern, M.A. (2003). Telomerase reconstitution immortalizes human fetal hepatocytes without disrupting their differentiation potential. Gastroenterology 124:432-444.
39. Willenbring, H., Bailey, A.S., Foster, M., Akkari, Y., Dorrell, C., Olson, S., Finegold, M., Fleming, W.H., and Grompe, M. (2004). Myelomonocytic cells are sufficient for therapeutic cell fusion in liver. Nat. Med. 10:744-748.
40. Xu, C., Inokuma, M.S., Denham, J., Golds, K., Kundu, P., Gold, J.D., and Carpenter, M.K. (2001). Feeder-free growth of undifferentiated human embryonic stem cells. Nat. Biotechnol. 19:971-974.
41. Yoon, J.H., Lee, H.V., Lee, J.S., Park, J.B., and Kim, C.Y. (1999). Development of a non-transformed human liver cell line with differentiated- hepatocyte and urea-synthetic functions: Applicable for bioartificial liver. Int. J. Artif. Organs 22:769-777.
42. Zeilinger, K., Holland, G., Sauer, I.M., Efimova, E., Kardassis, D., Obermayer, N., Liu, M., Neuhaus, P., and Gerlach, J.C. (2004). Time course of primary liver cell reorganization in three-dimensional high-density bioreactors for extracorporeal liver support: An immunohistochemical and ultrastructural study. Tissue Eng. 10:1113-1124.